IP Strategy Consultant, Managing Director, muu-IP, Switzerland
Dr. Leena Contarino has over two decades of experience in intellectual property and patent law. Before moving to Switzerland she served as a partner at the Boston, MA, office of Nixon Peabody LLP, a large general practice U.S. law firm. At Nixon Peabody, she served her clients for over 16 years mainly in creating patent strategies, drafting and prosecuting patent applications, and assisting in all aspects of intellectual property due diligence in commercial transactions, as well as providing invalidity and non-infringement analyses and supporting strategies for contentious matters. Leena moved to Switzerland as a VP of IP to set up an IP department at the newly established headquarters of Roivant Sciences, a multinational pharmaceutical company with a focus on repurposing drugs. At Roivant, Leena’s main focus was on due diligence of assets of interest and in creating IP strategies around the assets, as well as review of contracts relating to in-licensed IP. Leena also practiced as a partner at the Basel office of HGF, a UK-based patent law firm, and represented clients before the European Patent Office for over two years. At HGF, she further provided post-grant review support for a large multinational biosimilars company. Leena recently founded muu-IP GmbH, an IP strategy consulting firm focusing on assisting small and medium sized companies in creating business-supporting IP strategies. Leena is a qualified patent attorney before the United States Patent and Trademark Office and a licensed attorney before the courts of Commonwealth of Massachusetts. Her scientific qualifications include degrees of master of science in biotechnology from University of Kuopio, and doctor of philosophy in biochemistry from University of Helsinki, as well as a post-doctoral research study in cell biology at Harvard University, Boston, MA. Her legal qualifications include a Juris Doctor degree from the Suffolk University Law School, Boston, MA. Leena is also an authorized provider of IP pre-diagnostic service (IP Scan), an EUIPO-supported program for small and medium sized companies, coordinated by the Finnish Patent and Registration Office.